Search Results - "Dahal, B. K."

Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension by DAHAL, B. K, KOSANOVIC, D, GRIMMINGER, F, SEEGER, W, SCHERMULY, R. T, PAMARTHI, P. K, SYDYKOV, A, LAI, Y.-J, KAST, R, SCHIROK, H, STASCH, J.-P, GHOFRANI, H. A, WEISSMANN, N

“…An accumulating body of evidence incriminates Rho kinase (ROCK) in the pathogenesis of pulmonary hypertension (PH). The therapeutic efficacy of azaindole-1, a…”
Get full text

Inflammation, immunological reaction and role of infection in pulmonary hypertension by Pullamsetti, S.S., Savai, R., Janssen, W., Dahal, B.K., Seeger, W., Grimminger, F., Ghofrani, H.A., Weissmann, N., Schermuly, R.T.

“…Inflammation underlies a wide variety of physiological and pathological processes. Acute inflammation is the initial response of the body to harmful stimuli…”
Get full text

Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation by Raes, G, Brys, L, Dahal, B K, Brandt, J, Grooten, J, Brombacher, F, Vanham, G, Noel, W, Bogaert, P, Boonefaes, T, Kindt, A, Van den Bergh, R, Leenen, PJM, De Baetselier, P, Ghassabeh, G H

“…Molecular markers, especially surface markers associated with type II, cytokine‐dependent, alternatively activated macrophages (aaMF), remain scarce. Besides…”
Get full text

Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment by Veith, C, Zakrzewicz, D, Dahal, B K, Bálint, Z, Murmann, K, Wygrecka, M, Seeger, W, Schermuly, R T, Weissmann, N, Kwapiszewska, G

“…Chronic exposure to hypoxia induces a pronounced remodelling of the pulmonary vasculature leading to pulmonary hypertension (PH). The remodelling process also…”
Get more information

Inflammation, immunological reaction and role of infection in pulmonary hypertension : Pulmonary Vascular Disease and Infection by PULLAMSETTI, S. S, SAVAI, R, JANSSEN, W, DAHAL, B. K, SEEGER, W, GRIMMINGER, F, GHOFRANI, H. A, WEISSMANN, N, SCHERMULY, R. T

Get full text

Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases by ten Freyhaus, Henrik, Dagnell, Markus, Leuchs, Maike, Vantler, Marius, Berghausen, Eva M, Caglayan, Evren, Weissmann, Norbert, Dahal, Bhola K, Schermuly, Ralph T, Ostman, Arne, Kappert, Kai, Rosenkranz, Stephan

“…Platelet-derived growth factor (PDGF) plays a pivotal role in the pathobiology of pulmonary hypertension (PH) because it promotes pulmonary vascular…”
Get full text

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β by Dahal, Bhola K., Heuchel, Rainer, Pullamsetti, Soni Savai, Wilhelm, Jochen, Ghofrani, Hossein A., Weissmann, Norbert, Seeger, Werner, Grimminger, Friedrich, Schermuly, Ralph T.

“…Platelet-derived growth factor (PDGF) has been implicated in the pathobiology of vascular remodeling. The multikinase inhibitor imatinib that targets PDGF…”
Get full text

Novel Markers for Alternative Activation of Macrophages: Macrophage Galactose‐Type C‐Type Lectins 1 and 2 by Van Den Bergh, R., Hassanzadeh, G. H., Brys, L., Dahal, B. K., Brandt, J., Grooten, J., Brombacher, F., Vanham, G., Noël, W., Bogaert, P., Boonefaes, T., Kindt, A., De Baetselier, P., Raes, G.

“…In parallel with the Th1/Th2 dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in,…”
Get full text

Hypoxia Enhances Platelet-derived Growth Factor Signaling in the Pulmonary Vasculature by HIF-1α-dependent Downregulation of Protein Tyrosine Phosphatases by Freyhaus, H, Leuchs, M, Dagnell, M, Vantler, M, Caglayan, E, Weissmann, N, Schermuly, RT, Dahal, BK, Ostman, A, Kai, K, Rosenkranz, S

Get full text